Opinion: Why the FDA should not approve an ineffective multicancer screening test
“Telling more people they have cancer is not progress; progress is having fewer people die from cancer,” H. Gilbert Welch writes of Grail’s multicancer screening test.
This is a short extract from a report by STAT. The full text stays with the publisher — follow the link to read it there.
Read at source
